Business & Industry

AstraZeneca announces $50 billion of investment in the United States by 2030, building on America’s global leadership in medicines manufacturing and R&D. This investment is expected to create tens of thousands of new, highly skilled direct and indirect jobs...

LaNova Medicines, which happens to be a cancer drugmaker that previously licensed medicines to AstraZeneca as well as Merck & Co., has gone on to agree to get acquired by Sino BioPharmaceuticals in a deal worth almost $951 million. In...

The pharmaceutical business has a major economic influence on both local and worldwide markets, and it is always changing according to different market trends. Packaging is essential to this industry. At the moment, the packaging guarantees patient safety by offering...

It is well to be noted that the pharmaceutical sector has for long been characterized by its intricate, global supply chains designed in order to optimize production, decrease costs, and make sure that there is a timely delivery of...

Kuala Lumpur, 9 June 2025 - tHIS ASEAN 2025 today opened its doors at the Kuala Lumpur Convention Centre with the biggest and most diverse group of the region's healthcare ecosystem. The three-day exhibition, held from 9-11 June 2025,...

In a time characterized by accelerated innovation and ever-more complicated clinical environments, Asia is witnessing an invigorating shift in the role of Contract Research Organizations (CROs). Once seen as service organizations that assist in the pharmaceutical and biotech product...

API China, PHARMCHINA & NHNE 2025 Close in Guangzhou with Thumping Success, Solidifying China as a World Pharma Leader Guangzhou, May 24, 2025 — In a strong demonstration of innovation, industrial synergy, and global cooperation, the 92nd API China, 90th...